Company intelligence / Profile preview

Trial Interactive

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Trial Interactive provides an AI-powered, 21 CFR Part 11-compliant eClinical platform widely adopted by biopharmaceutical, biotechnology, medical device, and CRO companies for end-to-end clinical trial operations, including eTMF, CTMS, site management, collaboration, training, and compliance documentation. It accelerates timelines, reduces risk, and improves operational quality for sponsors and sites, but does not itself conduct therapeutic R&D or possess a drug development pipeline[1][2][3][4][7].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Gedeon RichterNumerous global pharma, biotech, and CRO clients (per case studies and platform usage, companies generally referenced as "sponsors, CROs, and sites")[1][2][3]

Beyond the preview

Go deeper on Trial Interactive.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trial Interactive.

Explore the full profile